Clinical Trials
8
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Investigation of the Ringer Perfusion Balloon Catheter (Ringer PTCA)
- Conditions
- Coronary Stenosis
- First Posted Date
- 2021-04-28
- Last Posted Date
- 2023-12-22
- Lead Sponsor
- Vascular Solutions LLC
- Target Recruit Count
- 60
- Registration Number
- NCT04862689
- Locations
- 🇺🇸
Torrance Memorial Medical Center, Torrance, California, United States
🇺🇸Brigham & Women's Hospital, Boston, Massachusetts, United States
🇺🇸St. Luke's Hospital, Kansas City, Missouri, United States
Investigation of the Ringer Perfusion Balloon Catheter
- Conditions
- Coronary Artery Perforation
- First Posted Date
- 2021-04-19
- Last Posted Date
- 2023-12-22
- Lead Sponsor
- Vascular Solutions LLC
- Target Recruit Count
- 30
- Registration Number
- NCT04849169
- Locations
- 🇺🇸
Piedmont Heart Institute, Atlanta, Georgia, United States
🇺🇸Emory Heart & Vascular Center, Atlanta, Georgia, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
Clinical Trial Assessing Non-Inferiority of Freeze Dried Plasma to Fresh Frozen Plasma in Reversing Warfarin
- Conditions
- Anticoagulant Reversal
- First Posted Date
- 2021-03-12
- Last Posted Date
- 2021-03-12
- Lead Sponsor
- Vascular Solutions LLC
- Target Recruit Count
- 28
- Registration Number
- NCT04794348
- Locations
- 🇺🇸
Hoxworth Blood Center, Cincinnati, Ohio, United States
Chronic Total Occlusion Percutaneous Coronary Intervention Study
- Conditions
- Chronic Total OcclusionChronic Total Occlusion of Coronary ArteryIschemic Heart Disease
- First Posted Date
- 2019-06-17
- Last Posted Date
- 2022-09-28
- Lead Sponsor
- Vascular Solutions LLC
- Target Recruit Count
- 150
- Registration Number
- NCT03988166
- Locations
- 🇺🇸
Torrance Memorial Medical Center, Torrance, California, United States
🇺🇸Piedmont Heart Institute, Atlanta, Georgia, United States
🇺🇸Emory University, Atlanta, Georgia, United States
Evaluation of an Absorbable Surgical Hemostatic Agent: Thrombi-Gel® Versus Gelfoam-Thrombin
- Conditions
- Operation Site Bleed
- First Posted Date
- 2008-04-03
- Last Posted Date
- 2016-03-07
- Lead Sponsor
- Vascular Solutions LLC
- Target Recruit Count
- 97
- Registration Number
- NCT00652314
- Locations
- 🇺🇸
Southern Illinois University School of Medicine, Springfield, Illinois, United States
🇺🇸Lahey Clinic, Burlington, Massachusetts, United States
🇺🇸Michigan Vascular Research Center, Flint, Michigan, United States
- Prev
- 1
- 2
- Next